Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We performed whole-genome sequencing and copy number variation (CNV) analysis of 100 pancreatic ductal adenocarcinomas (PDACs). Chromosomal rearrangements leading to gene disruption were prevalent, affecting genes known to be important in pancreatic cancer (TP53, SMAD4, CDKN2A, ARID1A and ROBO2) and new candidate drivers of pancreatic carcinogenesis (KDM6A and PREX2). Patterns of structural variation (variation in chromosomal structure) classified PDACs into 4 subtypes with potential clinical utility: the subtypes were termed stable, locally rearranged, scattered and unstable. A significant proportion harboured focal amplifications, many of which con...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden.We perfor...
Published online 25 February 2015Pancreatic cancer remains one of the most lethal of malignancies an...
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate of 4%...
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate of 4%...
none15Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Background: A deeper knowledge of the pancreatic cancer (PDAC) biology is needed to improve the prog...
Background: A deeper knowledge of the pancreatic cancer (PDAC) biology is needed to improve the prog...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden.We perfor...
Published online 25 February 2015Pancreatic cancer remains one of the most lethal of malignancies an...
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate of 4%...
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate of 4%...
none15Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Background: A deeper knowledge of the pancreatic cancer (PDAC) biology is needed to improve the prog...
Background: A deeper knowledge of the pancreatic cancer (PDAC) biology is needed to improve the prog...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...
Context: Pancreatic cancer (PC) is characterized by a 5 year survival rate of 4%. The molecular mech...